Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/X0M1 stock hub

FRA/X0M1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/X0M1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

424.1M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/X0M1FRA/X0M1

—

Loading chart…

In the news

Latest news · FRA/X0M1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E26.9

P25 n/aP50 n/aP75 n/a

ROE34.1

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/X0M1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	14
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 482.1M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 424.1M
Price	EUR 34.2
Price currency	EUR
Rev Per Employee	3,172,521.64x
Sic	2836
Symbol	fra/X0M1
Website	https://www.xoma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.72%
EV Earnings	30.57x
EV/EBIT	49.85x
EV/EBITDA	38.66x
EV/Sales	10.88x
P/B ratio	4.79x
P/E ratio	26.89x
P/S ratio	9.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.83%
EBITDA Margin	27.53%
Gross margin	96.72%
Gross Profit	EUR 43M
Gross Profit Growth	96.93%
Gross Profit Growth Q	71.67%
Gross Profit Growth3 Y	104.77%
Gross Profit Growth5 Y	11.54%
Net Income	EUR 15.8M
Net Income Growth5 Y	16.06%
Pretax Margin	61.01%
Profit Margin	60.81%
Profit Per Employee	EUR 1.1M
ROA	2.88
Roa5y	-1.21
ROCE	4.79
ROE	34.12
Roe5y	-3.9
ROIC	6.57
Roic5y	-3.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.19%
Cagr15y	-1.39%
Cagr1y	71.92%
Cagr3y	28.81%
Cagr5y	5.8%
EPS Growth5 Y	13.2
FCF Growth5 Y	-22.22%
OCF Growth5 Y	-22.23%
Revenue Growth	83.06x
Revenue Growth Q	57.87x
Revenue Growth3 Y	105.3x
Revenue Growth5 Y	12.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.21
Assets	EUR 232.3M
Cash	EUR 70.9M
Current Assets	EUR 99.4M
Current Liabilities	EUR 29.5M
Debt	EUR 112M
Debt EBITDA	EUR 8.96
Debt Equity	EUR 1.27
Equity	EUR 88.5M
Interest Coverage	0.87
Liabilities	EUR 143.7M
Long Term Assets	EUR 132.8M
Long Term Liabilities	EUR 114.2M
Net Cash	EUR -41.1M
Net Cash By Market Cap	EUR -9.69
Net Debt EBITDA	EUR 3.36
Net Debt Equity	EUR 0.46
Tangible Book Value	EUR 33.3M
Tangible Book Value Per Share	EUR 2.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.37
Net Working Capital	EUR 12M
Quick ratio	3.19
Working Capital	EUR 70.2M
Working Capital Turnover	EUR 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-53.68%
Payout Ratio	17.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	163.89%
1Y total return	71.86%
200-day SMA	26.16
3Y total return	113.75%
50-day SMA	27.43
50-day SMA vs 200-day SMA	50over200
5Y total return	32.56%
All Time High	321
All Time High Change	-89.35%
All Time High Date	2009-05-15
All Time Low	3.71
All Time Low Change	822.08%
All Time Low Date	2017-02-13
ATR	0.67
Ch YTD	59.81
High	34.6
High52	35
High52 Date	2026-05-06
High52ch	-2.29%
Low	34.2
Low52	18.8
Low52 Date	2026-02-11
Low52ch	81.92%
Ma50ch	24.69%
Price vs 200-day SMA	30.72%
RSI	71.54
RSI Monthly	62.27
RSI Weekly	69.27
Sharpe ratio	1.12x
Sortino ratio	1.65
Total Return	-53.68%
Tr YTD	59.81
Tr15y	-18.96%
Tr1m	20.42%
Tr1w	-0.58%
Tr3m	66.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 9.7M
Operating Income Growth Q	-91.99
Operating Income Growth5 Y	-1.72
Operating margin	21.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,932,585%
Net Borrowing	-8,986,701.3
Shares Insiders	2.8%
Shares Institutions	53.93%
Shares Qo Q	-0.25%
Shares Yo Y	53.68%
Short Ratio	5.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1.1x
Bv Per Share	6.03
Ch10y	163.9
Ch15y	-18.96
Ch1m	20.42
Ch1w	-0.58
Ch1y	71.86
Ch3m	66.02
Ch3y	113.8
Ch5y	32.56
Ch6m	19.58
Change	0%
Change From Open	-1.16
Close	34.2
Days Gap	1.17
Depreciation Amortization	2,520,143.1
Earnings Date	2026-05-15
EBIT	EUR 9.7M
EBITDA	EUR 12.2M
EPS	EUR 1.24
F Score	6
Financing CF	-22,538,537
Fiscal Year End	December
Founded	1,981
Graham Number	14.29438
Graham Upside	-58.2
Income Tax	EUR 87,725
Investing CF	43,339,606
Is Primary Listing	0
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Last Split Date	2016-10-18
Last Split Type	Reverse
Lynch Fair Value	EUR 20.42
Lynch Upside	-40.28
Ma150	26.12
Ma150ch	30.95%
Ma20	32.78
Ma20ch	4.33%
Net CF	23,246,300
Next Earnings Date	2026-05-15
Open	34.6
P OCF Ratio	173.4
Position In Range	0
Ppne	234,885.5
Price Date	2026-05-08
Price EBITDA	EUR 34.68
Ptbv Ratio	12.72
Relative Volume	20x
Revenue	44,415,303x
SBC By Revenue	18.05x
Share Based Comp	8,017,904
Tax By Revenue	0.2x
Tax Rate	0.32%
Tr6m	19.58%
Volume	0
Z Score	-4.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/X0M1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/X0M1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/X0M1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+53.9%

Share of float held by funds and institutions

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/X0M1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.5

Above 70: short-term overbought

Price vs 200-day MA

+30.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/X0M1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/X0M1 stock rating?

fra/X0M1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/X0M1 analysis?

The full report lives at /stocks/fra/X0M1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/X0M1?

The latest report frames fra/X0M1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/X0M1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.